Skip to Content

EGFR inhibitors

Other names: anti-EGFR, epidermal growth factor receptor inhibitors, erbB-1, HER-1

What are EGFR inhibitors?

Epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER-1) inhibitors are medicines that bind to certain parts of the EGFR and slow down or stop cell growth.

EGFR is a protein that is found on the surface of some cells that causes cells to divide when epidermal growth factor binds to it. EGFR is found at abnormally high levels in cancer cells, and EGFR activation appears to be important in tumor growth and progression. Some types of cancers show mutations in their EGFRs, which may cause unregulated cell division through continual or abnormal activation of the EGFR.

EGFR inhibitors can be classified as either:

  • tyrosine kinase inhibitors (TKI) (eg, erlotinib, gefitinib): these bind to the tyrosine kinase domain in the epidermal growth factor receptor and stop the activity of the EGFR
  • monoclonal antibodies (eg, cetuximab, necitumumab): these bind to the extracellular component of the EGFR and prevent epidermal growth factor from binding to its own receptor, therefore preventing cell division.

EGFR inhibitors may be used in the treatment of cancers that are caused by EGFR up-regulation, such as non-small-cell lung cancer, pancreatic cancer, breast cancer, and colon cancer.

List of EGFR inhibitors:

Filter by:
Drug NameView by: Brand | Generic Reviews Avg. Ratings
Iressa (Pro)
generic name: gefitinib
7 reviews
   
9.6
Tarceva (Pro)
generic name: erlotinib
38 reviews
   
8.6
Tykerb (Pro)
generic name: lapatinib
1 review
   
7.5
Nerlynx (Pro)
generic name: neratinib
4 reviews
   
7.0
Erbitux (Pro)
generic name: cetuximab
8 reviews
   
6.9
Vectibix (Pro)
generic name: panitumumab
3 reviews
   
4.5
Caprelsa (Pro)
generic name: vandetanib
0 reviewsAdd rating
Portrazza (Pro)
generic name: necitumumab
0 reviewsAdd rating
Tagrisso (Pro)
generic name: osimertinib
0 reviewsAdd rating

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide